Jili Hu

Jili Hu


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 January 2025 in Frontiers in Medicine
Verified
Journal Article
Open access
PDF file
YDYuchen Duan
Yuchen Duan
QZQingqing Zhou
Qingqing Zhou
YLYu Li
Yu Li
CQChi Qin
Chi Qin
ZWZiyang Wang
Ziyang Wang
JHJili Hu
Jili Hu
Introduction: Traditional Chinese Medicine (TCM) case records encapsulate vast clinical experiences and theoretical insights, holding significant research and practical value. However, traditional case studies face challenges such as large data volumes, complex information, and difficulties in efficient retrieval and analysis. This study aimed to address these issues by leveraging modern data techniques to improve access and analysis of TCM case records.Methods: A total of 679 case records from Wang Zhongqi, a renowned physician of Xin’an Medicine, a branch of TCM, covering 41 diseases, were selected. The study involved four stages: pattern layer construction, knowledge extraction, integration, and data storage and visualization. A large language model (LLM) was employed to automatically extract key entities, including symptoms, pathogenesis, treatment principles, and prescriptions. These were structured into a TCM case knowledge graph.Results: The LLM successfully identified and extracted relevant entities, which were then organized into relational triples. A TCM case query system based on natural language input was developed. The system’s performance, evaluated using the RAGAS framework, achieved high scores: 0.9375 in faithfulness, 0.9686 in answer relevancy, and 0.9500 in context recall; In human evaluations, the levels of safety and usability are significantly higher than those of LLMs without using RAG.Discussion: The results demonstrate that integrating LLMs with a knowledge graph significantly enhances the efficiency and accuracy of retrieving TCM case information. This approach could play a crucial role in modernizing TCM research and improving access to clinical insights. Future research may explore expanding the dataset and refining the query system for broader applications.

16 March 2024 in Scientific Reports
Verified
Journal Article
Open access
PDF file
CLCan Liu
Can Liu
KSKaijie Sun
Kaijie Sun
QZQingqing Zhou
Qingqing Zhou
YDYuchen Duan
Yuchen Duan
JSJianhua Shu
Jianhua Shu
JHJili Hu
Jili Hu
Chinese patent medicine (CPM) is a typical type of traditional Chinese medicine (TCM) preparation that uses Chinese herbs as raw materials and is an important means of treating diseases in TCM. Chinese patent medicine instructions (CPMI) serve as a guide for patients to use drugs safely and effectively. In this study, we apply a pre-trained language model to the domain of CPM. We have meticulously assembled, processed, and released the first CPMI dataset and fine-tuned the ChatGLM-6B base model, resulting in the development of CPMI-ChatGLM. We employed consumer-grade graphics cards for parameter-efficient fine-tuning and investigated the impact of LoRA and P-Tuning v2, as well as different data scales and instruction data settings on model performance. We evaluated CPMI-ChatGLM using BLEU, ROUGE, and BARTScore metrics. Our model achieved scores of 0.7641, 0.8188, 0.7738, 0.8107, and − 2.4786 on the BLEU-4, ROUGE-1, ROUGE-2, ROUGE-L and BARTScore metrics, respectively. In comparison experiments and human evaluation with four large language models of similar parameter scales, CPMI-ChatGLM demonstrated state-of-the-art performance. CPMI-ChatGLM demonstrates commendable proficiency in CPM recommendations, making it a promising tool for auxiliary diagnosis and treatment. Furthermore, the various attributes in the CPMI dataset can be used for data mining and analysis, providing practical application value and research significance.

22 May 2024 in Frontiers in Medicine
Verified
Journal Article
Open access
QZQingqing Zhou
Qingqing Zhou
CLCan Liu
Can Liu
YDYuchen Duan
Yuchen Duan
KSKaijie Sun
Kaijie Sun
YLYu Li
Yu Li
JHJili Hu
Jili Hu
Introduction: Large Language Models (LLMs) play a crucial role in clinical information processing, showcasing robust generalization across diverse language tasks. However, existing LLMs, despite their significance, lack optimization for clinical applications, presenting challenges in terms of illusions and interpretability. The Retrieval-Augmented Generation (RAG) model addresses these issues by providing sources for answer generation, thereby reducing errors. This study explores the application of RAG technology in clinical gastroenterology to enhance knowledge generation on gastrointestinal diseases.Methods: We fine-tuned the embedding model using a corpus consisting of 25 guidelines on gastrointestinal diseases. The fine-tuned model exhibited an 18% improvement in hit rate compared to its base model, gte-base-zh. Moreover, it outperformed OpenAI’s Embedding model by 20%. Employing the RAG framework with the llama-index, we developed a Chinese gastroenterology chatbot named “GastroBot,” which significantly improves answer accuracy and contextual relevance, minimizing errors and the risk of disseminating misleading information.Results: When evaluating GastroBot using the RAGAS framework, we observed a context recall rate of 95%. The faithfulness to the source, stands at 93.73%. The relevance of answers exhibits a strong correlation, reaching 92.28%. These findings highlight the effectiveness of GastroBot in providing accurate and contextually relevant information about gastrointestinal diseases. During manual assessment of GastroBot, in comparison with other models, our GastroBot model delivers a substantial amount of valuable knowledge while ensuring the completeness and consistency of the results.Discussion: Research findings suggest that incorporating the RAG method into clinical gastroenterology can enhance the accuracy and reliability of large language models. Serving as a practical implementation of this method, GastroBot has demonstrated significant enhancements in contextual comprehension and response quality. Continued exploration and refinement of the model are poised to drive forward clinical information processing and decision support in the gastroenterology field.

17 April 2025 in Scientific Reports
Verified
Journal Article
Open access
PDF file
WXWenjie Xuan
Wenjie Xuan
XLXiaofo Li
Xiaofo Li
HGHonglei Gao
Honglei Gao
LZLuyao Zhang
Luyao Zhang
JHJili Hu
Jili Hu
HKHongxing Kan
Hongxing Kan
Traditional methods for synthesizing nanozymes are often time-consuming and complex, hindering efficiency. Artificial intelligence (AI) has the potential to simplify these processes, but there are very few dedicated nanozyme databases available, limiting the resources for research and application. To address this gap, we developed AI-ZYMES, a comprehensive nanozyme database featuring 1,085 entries and 400 types of nanozymes. The platform incorporates several key innovations that distinguish it from existing databases: Firstly, standardized Data Curation: AI-ZYMES resolves inconsistencies in catalytic metrics (e.g., Km, Vmax), morphologies, and dispersion systems, enabling reliable cross-study comparisons, something that existing resources like DiZyme and nanozymes.net lack.Secondly, dual AI Framework: A gradient-boosting regressor predicts kinetic constants (Km, Vmax, Kcat) with an R2 up to 0.85, while an AdaBoost classifier identifies enzyme-mimicking activities based solely on nanozyme names, surpassing traditional random forest models in predictive accuracy.Lastly, ChatGPT-based Synthesis Assistant: The platform includes an AI-driven assistant for literature extraction (67.55% accuracy) and synthesis pathway generation via semantic analysis (90% accuracy). This reduces manual effort and minimizes errors in large language model outputs, ensuring high-quality results.These innovations make AI-ZYMES a valuable tool for accelerating nanozyme research and application, including antimicrobial therapy, biosensing, and environmental remediation. The platform improves data accessibility, reduces experimental redundancy, and speeds up the translation of discoveries into practical use. By bridging the data fragmentation and predictive limitations of existing systems, AI-ZYMES establishes a new benchmark for AI-driven advancements in nanomaterials.

9 September 2022 in Journal of Oncology
Verified
Journal Article
Open access
PDF file
JHJili Hu
Jili Hu
WYWeiqiang Yu
Weiqiang Yu
YDYuting Dai
Yuting Dai
CLCan Liu
Can Liu
YWYongkang Wang
Yongkang Wang
QWQingfa Wu
Qingfa Wu
Background. Gastric cancer (GC) is one of the deadliest cancers in the world, with a 5-year overall survival rate of lower than 20 for patients with advanced GC. Genomic information is now frequently employed for precision cancer treatment due to the rapid advancements of high-throughput sequencing technologies. As a result, integrating multiomics data to construct predictive models for the GC patient prognosis is critical for tailored medical care. Results. In this study, we integrated multiomics data to design a biological pathway-based gastric cancer sparse deep neural network (GCS-Net) by modifying the P-NET model for long-term survival prediction of GC. The GCS-Net showed higher accuracy (accuracy=0.844), area under the curve (AUC=0.807), and F1 score (F1=0.913) than traditional machine learning models. Furthermore, the GCS-Net not only enables accurate patient survival prognosis but also provides model interpretability capabilities lacking in most traditional deep neural networks to describe the complex biological process of prognosis. The GCS-Net suggested the importance of genes (UBE2C, JAK2, RAD21, CEP250, NUP210, PTPN1, CDC27, NINL, NUP188, and PLK4) and biological pathways (Mitotic Anaphase, Resolution of Sister Chromatid Cohesion, and SUMO E3 ligases) to GC, which is consistent with the results revealed in biological- and medical-related studies of GC. Conclusion. The GCS-Net is an interpretable deep neural network built using biological pathway information whose structure represents a nonlinear hierarchical representation of genes and biological pathways. It can not only accurately predict the prognosis of GC patients but also suggest the importance of genes and biological pathways. The GCS-Net opens up new avenues for biological research and could be adapted for other cancer prediction and discovery activities as well.

4 January 2023 in Frontiers in Genetics
Verified
Journal Article
Open access
CLCan Liu
Can Liu
YDYuchen Duan
Yuchen Duan
QZQingqing Zhou
Qingqing Zhou
YWYongkang Wang
Yongkang Wang
YGYong Gao
Yong Gao
JHJili Hu
Jili Hu
Background: Clinical diagnosis and treatment of tumors are greatly complicated by their heterogeneity, and the subtype classification of cancer frequently plays a significant role in the subsequent treatment of tumors. Presently, the majority of studies rely far too heavily on gene expression data, omitting the enormous power of multi-omics fusion data and the potential for patient similarities.Method: In this study, we created a gastric cancer subtype classification model called RRGCN based on residual graph convolutional network (GCN) using multi-omics fusion data and patient similarity network. Given the multi-omics data’s high dimensionality, we built an artificial neural network Autoencoder (AE) to reduce the dimensionality of the data and extract hidden layer features. The model is then built using the feature data. In addition, we computed the correlation between patients using the Pearson correlation coefficient, and this relationship between patients forms the edge of the graph structure. Four graph convolutional network layers and two residual networks with skip connections make up RRGCN, which reduces the amount of information lost during transmission between layers and prevents model degradation.Results: The results show that RRGCN significantly outperforms other classification methods with an accuracy as high as 0.87 when compared to four other traditional machine learning methods and deep learning models.Conclusion: In terms of subtype classification, RRGCN excels in all areas and has the potential to offer fresh perspectives on disease mechanisms and disease progression. It has the potential to be used for a broader range of disorders and to aid in clinical diagnosis.